Live Terminal
Telegram

Max Healthcare shares extend rise to 5th session, up 12% so far; here's why

Share on WhatsApp Telegram
⚡ Instant Key Takeaways (TL;DR)
🎯
Core Development: Max Healthcare shares extend rise to 5th session, up 12% so far; here's why
📊
Market & Financial Impact: The September quarter earnings of healthcare firms were strong, with overall revenue growth of 20-25 percent year-on-year.
💡
Actionable Insight: 🟢 Bullish Trigger: Positive business expansion or earnings beat may attract institutional and retail buying.

Max Healthcare Institute shares extended their gains for the fifth consecutive session on Tuesday, rising 3 percent to Rs 1,039 per share on the NSE amid sustained buying interest in healthcare stocks.

The stock has gained around 12 percent over the past five trading sessions.

The recent buying interest comes amid expectations that healthcare companies could increase prices of other services to offset the impact of price caps on oncology drugs.

The earnings impact of the price caps is expected to ease if companies raise prices for other services, according to Deepika Muraka, healthcare sector analyst at Choice Equity Broking, Informist reported.

Earlier, companies in the sector were estimated to face a 7 percent impact on their earnings before interest, tax, depreciation and amortisation (EBITDA). However, the impact could be limited to 2 percent if they increase prices of other services to offset the losses, Muraka said.

📰
Official Publisher Attribution: This report is aggregated from Moneycontrol. ZeroLive provides live aggregation, automated sentiment synthesis, and exchange disclosure monitoring for retail market participants.
Read Original Full Coverage on Moneycontrol ↗
⚡
Get Breaking Stock Alerts & Q-Results on Telegram
Real-time 1200x675 image cards and financial filings delivered instantly.
Join @Zerolive_news ↗
Link copied to clipboard! ✅